Clinical Trials on Niemann-Pick Disease Type A in Germany

Total 4319 results

Forschungsinstitut der Diabetes Akademie Mergentheim

Completed

Evaluation of a Diabetes Self-Management Education Program for Non-Intensified Insulin Therapy in Type 2 Diabetes (MEDIAS-2-CT)

Type 2 Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH
Heinrich-Heine University, Duesseldorf

Completed

Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects (DXM/AMT)

Type 2 Diabetes Mellitus

Germany
Novo Nordisk A/S

Enrolling by invitation

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® (pathfinder9)

Haemophilia A

Austria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
Philipps University Marburg Medical Center

Completed

CDRM Study: Computer-assisted Diabetes Risk Management-for Secondary and Tertiary Prevention of T2DM Complications (CDRM_DMP)

Diabetes Mellitus Type 2

Germany
MedImmune LLC

Completed

A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Sanofi

Completed

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Type 2 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Protina Pharmazeutische GmbH

Completed

Magnesium Supplementation in Type II Diabetes

Effect of Magnesium in Diabetes

Germany
Allergopharma GmbH & Co. KG

Completed

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Type I Allergy

Germany
Allergy Therapeutics

Completed

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Type I Hypersensitivity

Germany
Adocia

Completed

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1

Type 1 Diabetes Mellitus

Germany
Michael A. Nauck

Completed

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Type 2 Diabetes

Germany
Janssen R&D Ireland

Completed

A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Hepatitis C, Chronic

Spain, Germany, Poland
Novo Nordisk A/S

Completed

Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device (GoBolus)

Diabetes | Diabetes Mellitus, Type 1 Diabetes

Germany
Novo Nordisk A/S

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Cytos Biotechnology AG

Completed

Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany, Switzerland
GWT-TUD GmbH

Terminated

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Diabetes Mellitus Type 2

Germany
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Hepatitis B

Germany, United Kingdom, Belgium
University of Giessen
Numico Research

Completed

Metabolic Response of Slow Released Carbohydrates in Diabetes Mellitus

Type 2 Diabetes

Germany
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
University of Erlangen-Nürnberg Medical School

Completed

Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function

Diabetes Mellitus Type 2

Germany
Institut für Pharmakologie und Präventive Medizin
University of Erlangen-Nürnberg Medical School

Completed

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes (ELMI)

Diabetes Mellitus Type 2

Germany
University of Erlangen-Nürnberg Medical School

Completed

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Forschungsinstitut der Diabetes Akademie Mergentheim

Completed

Evaluation of a Self-management Oriented Diabetes Education Program for Intensified Insulin Therapy in Type 2 Diabetes (MEDIAS-2-ICT)

Type 2 Diabetes

Germany
Dompé Farmaceutici S.p.A

Completed

Reparixin in Pancreatic Islet Transplantation

Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus

Italy, Germany
German Diabetes Center

Completed

Assessment of Liver Glucose Metabolism in Diabetic Subjects (CLAVA)

Newly Diagnosed Type 2 Diabetes (During the Last 12 Months)

Germany
University of Erlangen-Nürnberg Medical School

Completed

Effect of Pioglitazone on Ambulatory Blood Pressure

Hypertension | Diabetes Mellitus Type 2

Germany
Hoffmann-La Roche

Completed

A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin

Diabetes Mellitus Type 2

Germany
Novo Nordisk A/S

Completed

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Germany
Sana Klinikum Offenbach
Wuerzburg University Hospital; Kuwait University; Cleveland Clinic Florida; SRH...

Completed

Long-term Results After Bariatric Surgery in Type 1 Diabetes Patients

Bariatric Surgery Status in T1D

Germany
Charite University, Berlin, Germany
Wilhelm-Doerenkamp-Foundation (Funding)

Recruiting

Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients (NIMROD)

Type 2 Diabetes | NAFLD

Germany
Adocia
Eli Lilly and Company

Completed

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
University of Jena

Unknown

Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes

Type 2 Diabetes

Germany
Novo Nordisk A/S

Recruiting

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4) (FRONTIER4)

Haemophilia A With Inhibitors | Haemophilia A

Taiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, China, Portugal, Lithuania, Turkey, South Africa, Ireland, Italy, France, Japan, Belgium, Malaysia, Poland, Austria, Bulgaria, Denmark, Germany and more
Novo Nordisk A/S

Completed

Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
RWTH Aachen University
Novo Nordisk A/S

Withdrawn

Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease (Lirabolic)

Cardiovascular Diseases | Type 2 Diabetes

Germany
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Characteristics of Empagliflozin Initiators

Type 2 Diabetes

Germany
Swedish Orphan Biovitrum
Syneos Health

Active, not recruiting

A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa (FREEDOM)

Hemophilia A, Severe

Germany, Spain, France, Czechia, Netherlands, Ireland, Austria, Croatia, Greece, Italy, Norway, Slovenia, Sweden, United Kingdom
Novo Nordisk A/S

Completed

Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
German Diabetes Center
German Institute of Human Nutrition; Association of Statutory Health Insurance...

Completed

The Impact of a Diabetes Risk Prediction Model in Primary Care.

Type 2 Diabetes Mellitus | Primary Prevention

Germany
Profil Institut für Stoffwechselforschung GmbH
European Union

Completed

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Diabetes Mellitus Type 1

Germany
Forschungsinstitut der Diabetes Akademie Mergentheim

Completed

Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Germany
Technische Universität Dresden

Completed

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

Myeloid Leukemia

Germany
RWTH Aachen University

Terminated

Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus (Lina-Plaque)

Diabetes Mellitus Type 2 (T2DM) | Vascular Inflammation | Plaque Morphology

Germany, Netherlands
Novo Nordisk A/S

Completed

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Technical University of Munich

Unknown

Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes | Children

Germany

3

Subscribe